πŸ‡ΊπŸ‡Έ FDA
Patent

US 7214495

Screening method

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 7214495 (Screening method) held by Takeda Pharmaceutical Company Limited expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/505, A61K38/00, A61K39/00, A61K48/00